161/330US=49-D / Câncer
Fre S, Vignjevic D, Schoumacher M, Duffy SL, Janssen KP, Robine S, Louverd D. Epithelial morphogenesis and intestinal cancer: new insights in signaling mechanisms. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 85-111. ISBN 978-0-12-374358-9.

MORFOGENESE EPITELIAL; CANCER INTESTINAL; MECANISMOS DE SINALIZACAO; EPITELIO INTESTINAL; SINALIZADOR WNT; SINALIZACAO NOTCH; SINALIZACAO DO OURICO; SINALIZACAO DE PROTEINA MORFOGENETICA OSSEA (BMP); PTEN (FOSFATASE E HOMOLOGO TENSINA); RECEPTORES TIROSINA-QUINASES; B-CATENIN

162/330US=57 / Biol/Mol
Weinberg RA. Fatores de crescimento, receptores e câncer. In: ___. A biologia do câncer. Porto Alegre: Artmed, 2008. p. 119-58. ISBN 978-85-363-1348-1.

FATORES DE CRESCIMENTO CELULAR; RECEPTORES; CANCER; CELULAS CANCERIGENAS; ONCOPROTEINA; TRANSFOSFORILACAO; RECEPTORES TIROSINA CINASE; PROTEINA RAS

163/330US=57 / Biol/Mol
Weinberg RA. O circuito da sinalização citoplásmica programa muitos dos traços de câncer. In: ___. A biologia do câncer. Porto Alegre: Artmed, 2008. p. 159-208. ISBN 978-85-363-1348-1.

CIRCUITO DA SINALIZACAO CITOPLASMICA; CANCER; DOENCA DE PROLIFERACAO CELULAR DESCONTROLADA; PROTEINA RAS

164/330US=65 / Biol/Mol
Enoksson M, Zhu W, Salvesen GS. Identification of protease substrates by mass spectrometry approaches-1. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 67-82. ISBN 978-0-387-69056-8.

IDENTIFICACAO DE SUBSTRATOS DA PROTEASE; ESPECTROMETRIA DE MASSA; SUBSTRATOS NATURAIS; METODOS PROTEOMICOS; PROTEINA; PEPTIDEO; ROTULAGEM ICAT; REAGENTES AMINO-REATIVOS; ROTULAGEM ITRAQ; PEPTIDEOS TRIPTICOS; ROTULO ISENTO DE ANALISE

165/330US=67 / Biol/Mol
Neckers L, Ivy P. 17-AAG: targeting the molecular chaperone heat shock protein 90. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 75-95. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

17-AAG; CHAPERONE; PROTEINA DE CHOQUE TERMICO 90; CANCER; CHAPERONE MOLECULAR; TERAPIA ALVO; PLASTICIDADE GENETICA; ONCOGENE; GELDANAMICINA; ANSAMICINA BENZOQUINONA

166/330US=70 / Biol/Mol
Bunz F. Cancer gene pathways. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 173-226. ISBN 978-1-4020-6783-9.

CANCER; GENE; VIAS; VIAS CELULARES; INTERACAO PROTEINA-PROTEINA; REACOES BIOQUIMICAS; FOSFORILACAO DE PROTEINAS; SINAIS DA SUPERFICIE CELULAR; TIROSINA-QUINASES PROTEICAS; VIA RAS; FOSFORILACAO DE LIPIDIOS; VIA PI3K/AKT; MORFOGENESE; VIA WNT/APC; HOMEOSTASE; ATIVACAO P53; MDM2; APOPTOSE; CICLO CELULAR

167/330US=8 / Dermatologia
Gallo RL, Trowbridge JM. Proteoglycans and glycosaminoglycans of skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 210-6. ISBN 978-0-07138076-0.

PELE; PROTEOGLICANOS; GLICOSAMINOGLICANOS; PROTEINA DO CORE

168/330US=80 / Biol/Mol
Jain KK. Tumor proteomics: oncoproteomics for personalized management of cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 81-99. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7.

MICROARRAYS DE PROTEINA; DROGAS ANTICANCER; BIOMARKETING; CANCER; ONCOPROTEOMICS; MEDICINA PERSONALIZADA; FARMACOGENOMICA; PHARMACOPROTEOMICS; PERFIL DE PROTEINAS; PROTEOMICA

169/330US=84 / Biol/Mol
Todorovic V, Rifkin DB. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B availability: latent TGF-B and latent TGF-B binding proteins. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 37-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; LATENCIA PROTEINA ASSOCIADA; LATENCIA ASSOCIADA PROTEINA LATENTE; PROTEINA TGF-B DE LIGACAO; MATRIZ EXTRACELULAR; PLASMINA; THROBOSPODIN-1

170/330US=84 / Biol/Mol
Jin Q, Gao G, Mulder KM. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: involvement of km23 dynein light chains in TGF B signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 169-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

KM23; TGF-B; DINEINA; TRANSDUCAO DE SINAL; CANCER; FATOR DE CRESCIMENTO; PROTEINA MOTOR; DYNLRB; SMAD; TRAFICO

171/330US=84-A / Biol/Mol
Ungefroren H. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling and biglycan in pancreatic cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 51-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

CANCER DE PANCREAS; RECEPTOR; SMAD; BIGLICAM; PARAGEM DO CRESCIMENTO; DANO DO DNA-45B; P38 CINASE DE PROTEINA ACTIVADA POR MITOGENIO; NADPH OXIDASE; PROTEINA QUINASE C; FACTOR DE CRESCIMENTO TRANSFORMANTE-B

172/330US=84-A / Biol/Mol
Barrios-Rodiles M, Viloria-Petit A, Brown KR, Jurisica I, Wrana JL. Transformig growth factor-B in developing and advanced cancers: high-throughput screening of protein interaction networks in the TGFB interactome: understanding the signaling mechanisms driving tumor progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 265-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

RENDIMENTO ELEVADO; INTERACOES PROTEINA-PROTEINA; REDES; EMT; METASTASE

173/330US=84-A / Biol/Mol
Hoffmann FM, Cui Q, Lim SK, Zhao BM. Development of inhibitors of transforming growth factor-B signaling for therapy: targeting smad-dependent TGF-B signaling with peptide aptamers. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 737-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

APTAMEROS PEPTIDEO; MOTIVO DE PROTEINA; PROTEINA ANDAIME; SMAD; TGF-B INIBIDORES

174/330US=8-A / Dermatologia
Bickers DR, Frank J. The porphyrias. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1435-66. ISBN 978-0-07-138076-0.

PORFIRIAS; BIOSSINTESE DA PORFIRINA; PROTEINA HEME; LESOES CUTANEAS; PORFIRIAS. CLASSIFICACAO; PORFIRIAS. TRATAMENTO; PORFIRIAS. PREVENCAO; PSEUDOPORFIRIA; FOTOSSENSIBILIDADE BOLHOSA; PROTOPORFIRIA ERITROPOIETICA; PORFIRIA ERITROPOIETICA CONGENITA; PORFIRIA HEPATOERITROPOIETICA

175/330US=440 / Tese/FAP
Sousa EA. Linfangiogênese em carcinoma epidermóide oral e associação com características clinicopatológicas. [Lymphangiogenesis in oral squamous cell carcinoma and association with clinicopathological characteristics]. São Paulo, 2012. 72 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/ElenAlvesSousa/ElenAlvesSousa.pdf

Curriculum Lattes

LINFANGIOGENESE; CARCINOMA DE CELULAS ESCAMOSAS; CAVIDADE ORAL; NEOPLASIAS DE CABECA E PESCOCO; IMUNOISTOQUIMICA; MARCADORES BIOLOGICOS DE TUMOR

176/330US=90 / Biol/Mol
Xu W, Neckers L. EGFR signaling networks: differential dependence of EGFR and ErbB2 on the molecular chaperone Hsp90. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 63-71. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CHAPERONES MOLECULARES; PROTEINA DE CHOQUE TERMICO 90; ANSAMICINAS BENZOQUINONA; GELDANAMICINA; HSP90 INIBIDOR; MUTACOES DE EGFR; SENSIBILIDADE AO FARMACO

177/330US=1 / Química
Fraser WD. Sangue: células e proteínas do plasma. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 27-37. ISBN 85-3522298-2.

PLASMA; SORO; ERITROCITOS; LEUCOCITOS; TROMBOCITOS; PLAQUETA; PROTEINAS; ALBUMINA; IONS DE METAIS; IMUNOGLOBULINAS; PROTEINA C-REATIVA

178/330US=1 / Química
Harnett MM, Goodridge HS. Receptores de membrana e transdução de sinal. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 557-74. ISBN 85-3522298-2.

RECEPTORES HORMONAIS; HORMONIOS ESTEROIDES; HORMONIOS PEPTIDIOS; TRANSDUCAO DO SINAL INTRACELULAR; PROTEINA G; AMP CICLICO; PROTEINA QUINASE A; FOSFODIESTERASES; ION CALCIO; CALMODULINA; FOSFATIDILINOSITOL 4,5-BIFOSFATO; 1,4,5-TRIFOSFATO DE INOSITOL; DIACILGLICEROL; FOSFOLIPASE; ACIDO ARAQUIDONICO; EICOSANOIDES; LEUCOTRIENO

179/330US=7 / Transplante
Borlongan CV, Stahl CE, Yu G, Xu L, Yasuhara T, Hara K, Matsukawa N, Sanberg PR, Wang Y, Hess DC. Cell therapy for CNS diseases: NT2N cell transplantation and GDNF treatment in stroke: linking neurotrophic factor therapy and neuroprotection. In: Halberstadt C, Emerich D, editors. Cellular transplantation: from laboratory to clinic. Amsterdam: Elsevier, 2007. p. 353-71. ISBN 978-0-12-369415-7.

TERAPIA CELULAR; DOENCAS PARA SISTEMA NERVOSO CENTRAL; CELULA NT2N; PROTEINA GDNF; FATORES NEUROTROFICOS; NEUROPROTECAO

180/330US=111 / Câncer
Wallace SW, Jaffe AB. Signalling by Ras and Rho GTPases. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 226-41. ISBN 978-0-470-01852-1.

CANCER; SINALIZACAO DE RAS; RHO GTPASES; PROTEINA RAF; PL3K; RALGDS

Primeira | Anterior | Próxima | Última